Abstract
8258 Haptoglobin-related protein (HPR) new role as insulin secretion enhancer
Journal of the Endocrine Society, Vol.8(Suppl 1)
10/05/2024
DOI: 10.1210/jendso/bvae163.793
Abstract
Disclosure: C. Viesi: None. Type 2 Diabetes (T2D) affects over 530 million people around the globe. Insulin resistance, encompassing tissues such as muscle, adipose, and liver, is the initial step hallmarked by hyperinsulinemia. Coupled with β-cell failure, these coordinated responses progress to T2D, becoming irreversible and medically challenging. Despite the well-established requirement for communication between pancreas and peripheral tissues in T2D progression, this area remains almost entirely unexplored. Here, we performed a human population genetic screening across 310 individuals to search for new endocrine regulators of pancreas function. Specifically, global gene expression from 18 peripheral tissues was analyzed to identify potential endocrine regulators of insulin secretion. This analysis prioritized liver-specific Haptoglobin-related protein (HPR) as genetically-enriched with islet insulin responses. Mouse models using AAV technology and acute protein administration of HPR showed that this newly secreted protein is sufficient to prevent diet-induced insulin resistance through enhanced beta-cell respiration. When mice were administered soluble HPR, then pancreatic tissue subjected to global RNA-sequencing, enhanced respiration pathways were observed. Next, we generated hepatocyte-specific overexpression models using AAV, which were sufficient to rescue whole-body glucose disposal profiles and weight gain in diet-induced insulin-resistant mice. Altogether, these findings highlight HPR as a novel soluble protein which signals from liver to pancreatic islets. Presentation: 6/3/2024
Details
- Title: Subtitle
- 8258 Haptoglobin-related protein (HPR) new role as insulin secretion enhancer
- Creators
- Carlos Viesi - University of California, IrvineIan Tamburini - University of California, IrvineHosung Bae - University of California, IrvineErwin Ilegems - Novo Nordisk (Denmark)Leandro Velez - University of California, IrvineMingqi Zhou - University of California, IrvineChristy Nguyen - University of California, IrvineCasey Johnson - University of California, IrvineCholsoon Jang - University of California, IrvineErika Nishimura - Novo Nordisk (Denmark)Marcus Seldin - University of California, Irvine
- Resource Type
- Abstract
- Publication Details
- Journal of the Endocrine Society, Vol.8(Suppl 1)
- DOI
- 10.1210/jendso/bvae163.793
- ISSN
- 2472-1972
- eISSN
- 2472-1972
- Publisher
- Oxford University Press
- Language
- English
- Date published
- 10/05/2024
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985217112302771
Metrics
1 Record Views